Target intelligence / Profile preview

Cyclic nucleotide-gated channel alpha subunit (CNGA)

Target
CNGA
Molecular classification
Ion channel, Cyclic nucleotide-gated channel, Membrane protein
01

Overview

Cyclic nucleotide-gated channel alpha subunits (typically abbreviated as CNGA) are *pore-forming* proteins that assemble into tetrameric ion channels activated by the direct binding of cyclic nucleotides (mainly cGMP or cAMP)[1][3]. They are essential in the sensory transduction pathways of photoreceptor cells (vision) and olfactory sensory neurons (smell), where they convert chemical signals (levels of cAMP or cGMP) into electrical signals by mediating sodium and calcium influx[1][3][4]. Each alpha subunit spans the membrane six times (S1–S6), has a pore-forming P-loop, and a cytoplasmic cyclic nucleotide-binding domain[1][2]. These channels are critical for the electrical responses to light and odors[3]. Mutations in specific alpha subunits—such as CNGA1—can result in severe hereditary diseases, including retinitis pigmentosa, due to disruption of phototransduction in retinal rods[4]. Their pharmacology is an area of active research, with some non-specific modulators identified, but no highly specific drugs currently in widespread clinical use[5][3].

Other names
CNGA subunitCyclic nucleotide-gated channel alpha 1 (CNGA1)alpha 2 (CNGA2)alpha 3 (CNGA3)alpha 4 (CNGA4)CNG channel alpha subunitCyclic nucleotide-regulated channel alpha subunit
02

Mechanism of action

Channel blockade (e.g., small molecule inhibitors block ion flow through CNG channels); Modulation of cyclic nucleotide (cAMP/cGMP) binding to the intracellular domain

03

Biological functions

Signal transductionSensory transduction (vision and olfaction)Ion homeostasis
04

Disease associations

Neurodegenerative disease (e.g., retinitis pigmentosa due to mutations in CNGA1)Other sensory disorders (e.g., olfactory dysfunction)Potential cardiovascular roles (through related channels)
05

Safety considerations

Potential for vision loss or olfactory dysfunction if channel function is lost or excessively inhibitedOff-target effects from non-selective inhibitors due to channel family similarities
06

Interacting drugs

H-8 (a non-specific cyclic nucleotide-dependent protein kinase inhibitor, shown to block CNG alpha subunits)

1 more in the full profile.

07

Biomarkers

Mutational analysis of CNGA1 gene for inherited retinal degenerations (e.g., retinitis pigmentosa)Expression analysis in sensory tissues (retina, olfactory epithelium)

Beyond the preview

Go deeper on Cyclic nucleotide-gated channel alpha subunit (CNGA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclic nucleotide-gated channel alpha subunit (CNGA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call